Peters James J 4
4 · NxStage Medical, Inc. · Filed Feb 25, 2019
Insider Transaction Report
Form 4Exit
Peters James J
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
[F1]2019-02-21−15,643→ 0 totalExercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
[F1]2019-02-21−17,537→ 0 totalExercise: $19.03From: 2016-07-24Exp: 2023-06-23→ Common Stock (17,537 underlying)
Footnotes (1)
- [F1]This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
Signature
/s/ Aras Lapinskas, attorney in fact for James Peters|2019-02-25